BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17692646)

  • 21. Applicability of the Milan criteria for determining liver transplantation as a first-line treatment for hepatocellular carcinoma.
    Morioka D; Tanaka K; Matsuo K; Takeda K; Ueda M; Sugita M; Nagano Y; Endo I; Sekido H; Togo S; Shimada H
    Ann Surg Oncol; 2006 Nov; 13(11):1500-10. PubMed ID: 17009137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Undetected hepatocellular carcinoma in patients undergoing liver transplantation: is associated with favorable outcome.
    Urahashi T; Lynch SV; Kim YH; Balderson GA; Fawcett JW; Crawford DH; Strong RW
    Hepatogastroenterology; 2007 Jun; 54(76):1192-5. PubMed ID: 17629068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis.
    Rayya F; Harms J; Bartels M; Uhlmann D; Hauss J; Fangmann J
    Transplant Proc; 2008 May; 40(4):933-5. PubMed ID: 18555082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation for hepatocellular carcinoma in New Zealand: a prospective intent-to-treat analysis.
    Marui Y; McCall J; Gane E; Holden A; Duncan D; Yeong ML; Chow K; Munn S
    N Z Med J; 2005 Jun; 118(1217):U1532. PubMed ID: 15980906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
    Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Aishima S; Terashi T; Shimada M; Maehara Y
    Transplantation; 2007 Apr; 83(7):893-9. PubMed ID: 17460559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Silva M; Moya A; Berenguer M; Sanjuan F; López-Andujar R; Pareja E; Torres-Quevedo R; Aguilera V; Montalva E; De Juan M; Mattos A; Prieto M; Mir J
    Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of the listing criteria justified?
    Sotiropoulos GC; Malagó M; Bockhorn M; Schmitz KJ; Radtke A; Molmenti EP; Schaffer R; Beckebaum S; Cicinnati VR; Fouzas I; Broelsch CE; Lang H
    Hepatogastroenterology; 2008; 55(86-87):1671-7. PubMed ID: 19102367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
    Scatton O; Zalinski S; Terris B; Lefevre JH; Casali A; Massault PP; Conti F; Calmus Y; Soubrane O
    Liver Transpl; 2008 Jun; 14(6):779-88. PubMed ID: 18508370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma.
    Baccarani U; Isola M; Adani GL; Benzoni E; Avellini C; Lorenzin D; Bresadola F; Uzzau A; Risaliti A; Beltrami AP; Soldano F; De Anna D; Bresadola V
    Transpl Int; 2008 Mar; 21(3):247-54. PubMed ID: 18028264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma.
    Takada Y; Ueda M; Ito T; Sakamoto S; Haga H; Maetani Y; Ogawa K; Kasahara M; Oike F; Egawa H; Tanaka K
    Liver Transpl; 2006 Jun; 12(6):912-9. PubMed ID: 16489583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
    Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
    Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
    Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD
    Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution.
    Shah SA; Cleary SP; Tan JC; Wei AC; Gallinger S; Grant DR; Greig PD
    Ann Surg Oncol; 2007 Sep; 14(9):2608-14. PubMed ID: 17522942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Liver transplantation for hepatocellular carcinoma].
    Suh KS; Yi NJ
    Korean J Hepatol; 2006 Dec; 12(4):493-506. PubMed ID: 17237627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL; Zang YJ; Chen XG; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].
    Fan J; Zhou J; Xu Y; Qiu SJ; Wu ZQ; Yu Y; Huang XW; Tang ZY; Wang YQ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1227-31. PubMed ID: 16796876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.